A New Era of Precision Imaging for Venous Thromboembolism – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jamal Elhasnaoui et al., adding:
“Nuclear molecular imaging of venous thromboembolism: targeting clot-specific molecular components for improved diagnosis and management
Today’s clot imaging shows structure and perfusion but little about clot biology. This review surveys nuclear molecular imaging that targets clot-specific components, using PET to read molecular processes in living tissue.
Paired with high-throughput methods, such approaches could yield precision imaging biomarkers and move venous thromboembolism care toward molecularly informed diagnosis and treatment.”
Title: Nuclear molecular imaging of venous thromboembolism: targeting clot-specific molecular components for improved diagnosis and management
Authors: Jamal Elhasnaoui, Philippe Robin, Catherine A. Lemarie
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland
-
Oct 17, 2026, 16:48Kalyan Roy: Enhancing Patient Experience Through Learning and Collaboration
-
Oct 17, 2026, 16:43Wilfried Dinh: Antiplatelet Therapy in 2026: Duration is Becoming a Dynamic Decision
-
Oct 17, 2026, 16:37Ian Setchfield: Dr. Evans Presents on Safe Anticoagulation Prescribing at East Kent Hospitals
-
Oct 17, 2026, 16:33Lewis Thomas: Connecting Through Shared Experiences at ASCAT 2026
-
Oct 17, 2026, 16:29Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period